Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Cannon

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Rheumatic Diseases Clinics of North America|November 15, 1997
Methotrexate pulmonary toxicityG W Cannon
Drugs of Today (Barcelona, Spain : 1998)|July 25, 2003
Rofecoxib: a specific cyclooxygenase inhibitorG W Cannon
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Cyclooxygenase-2 selective inhibitorsG W Cannon
Seminars in Arthritis and Rheumatism|June 1, 1990
Pulmonary complications of antirheumatic drug therapyG W Cannon
Bailliere'S Clinical Rheumatology|February 1, 1993
Antirheumatic drug reactions in the lungG W Cannon
The Journal of Rheumatology|April 1, 1990
Inhibition of the passive transfer of adjuvant induced arthritis by gold sodium thiomalateG W Cannon, S McCall
Clinical and Experimental Rheumatology|November 24, 2004
Benefit/risk of leflunomide in rheumatoid arthritisJ M Kremer, G W Cannon
Transplantation Proceedings|October 1, 1993
Background genes confer protection against homologous rat type II collagen-induced arthritis in ACI (RT1a) ratsM M Griffiths, G W Cannon
The American Journal of Medicine|February 15, 2001
Efficacy of cyclooxygenase-2-specific inhibitorsG W Cannon, F C Breedveld
Agents and Actions|January 1, 1992
The effects of flurbiprofen on the passive transfer of adjuvant-induced arthritisG W Cannon, D S Harper
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Rheumatic Diseases Clinics of North America|November 15, 1997
Methotrexate pulmonary toxicityG W Cannon
Drugs of Today (Barcelona, Spain : 1998)|July 25, 2003
Rofecoxib: a specific cyclooxygenase inhibitorG W Cannon
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Cyclooxygenase-2 selective inhibitorsG W Cannon
Seminars in Arthritis and Rheumatism|June 1, 1990
Pulmonary complications of antirheumatic drug therapyG W Cannon
Bailliere'S Clinical Rheumatology|February 1, 1993
Antirheumatic drug reactions in the lungG W Cannon
The Journal of Rheumatology|April 1, 1990
Inhibition of the passive transfer of adjuvant induced arthritis by gold sodium thiomalateG W Cannon, S McCall
Clinical and Experimental Rheumatology|November 24, 2004
Benefit/risk of leflunomide in rheumatoid arthritisJ M Kremer, G W Cannon
Transplantation Proceedings|October 1, 1993
Background genes confer protection against homologous rat type II collagen-induced arthritis in ACI (RT1a) ratsM M Griffiths, G W Cannon
The American Journal of Medicine|February 15, 2001
Efficacy of cyclooxygenase-2-specific inhibitorsG W Cannon, F C Breedveld
Agents and Actions|January 1, 1992
The effects of flurbiprofen on the passive transfer of adjuvant-induced arthritisG W Cannon, D S Harper
Pageof 8